PharmaCyte Biotech Inc. (PMCB) Social Stream



PharmaCyte Biotech Inc. (PMCB): $1.72

0.07 (-4.01%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

C

Add PMCB to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#60 of 390

in industry

PHARMACYTE BIOTECH INC (PMCB) Price Targets From Analysts

Use the tables below to see what analysts covering PHARMACYTE BIOTECH INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
NA 1 $NA $NA $NA $2.15 NA%

Price Target Last Issued NA NA, NA

PMCB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 1 0 0 1

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, PHARMACYTE BIOTECH INC's number of analysts covering the stock is greater than just about none of of them.
  • In the context of stocks in the micro market cap category, PHARMACYTE BIOTECH INC's variance in analysts' estimates is lower than nearly 100% of them.
  • In terms of how PHARMACYTE BIOTECH INC fares relative to stocks in the micro market cap category, note that its average analyst price target is greater than just about none of of that group.
  • PMCB has a higher upside potential (average analyst target price relative to current price) than just about none of of stocks in the micro market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to PHARMACYTE BIOTECH INC are HUGE, MDWD, and CYAN.

What is the outlook for PMCB? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!